TFF Doubles In 30 Days, Raising Buy Up To Price To $15
Only 30 days after I pegged TFF Pharmaceuticals, Inc. (TFFP) as the next potential multi-billion-dollar biotech platform, management just delivered.
Your account
Sign inResearch Links
Recent Posts
- PRVB: Q3 2022 Update & Outlook
- Q2 2022 Portfolio Review & Outlook
- ATOM: Lands Another “Major” Foundry Customer, Plus 10 Takeaways From Q1 Report
- [IMNM] Biotech Absurdity
- [Video] Cue Biopharma Q&A Session With Dr. D.J. Verret
- [Video] ATOM: 5 Key Takeaways From The Q4 2021 Report
- RESN: Time To Lock In Our 5G Gains